Abstract
Disc diffusion testing by Kirby-Bauer technique is the most used method for determining antimicrobial susceptibility in microbiological laboratories. The current guidelines by The Clinical and Laboratory Standards Institute (CLSI) 2022 specify using an 18- to 24-h growth for testing by disc diffusion. We aim to determine if using an early growth (6 h and 10 h) would produce comparable results, thus ultimately leading to reduced turnaround time. Six-hour, 10-h, and 24-h growths of 20 quality control strains and 6-h and 24-h growths of 48 clinical samples were used to perform disc diffusion testing using a panel of appropriate antimicrobial agents. Disc diffusion zone sizes were interpreted for all and comparative analyses were performed to determine categorical agreement, minor errors (mE), major errors (ME), and very major errors (VME) according to CLSI guidelines. On comparing with the standard 24 h of incubation, disc diffusion from 6-h and 10-h growths of quality control strains showed 94.38% categorical agreement, 5.10% mE, 0.69% MEs, and no VMEs. Disc diffusion testing for the additional 40 clinical samples yielded a similarly high level of categorical agreement (98.15%) and mE, ME, and VME of 1.29%, 1.22%, and 0% respectively. Disc diffusion testing using early growth is a simple and accurate method for susceptibility testing that can reduce turnaround time and may prove to be critical for timely patient management.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
Code availability
Not applicable.
References
Bauer AW, Kirby WMM, Sherris JC et al (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493–496
Clinical and Laboratory Standards Institute (2022) Performance standards for antimicrobial susceptibility testing M100, 32nd edn. CLSI, Wayne, PA, USA
Food and Drug Administration (2017) 21st Century Cures Act: announcing the establishment of the Susceptibility Test Interpretive Criteria Website. Fed Regist 82:58617–58618
Humphries RM, Ferraro MJ, Hindler JA (2018) Impact of 21st Century Cures Act on breakpoints and commercial antimicrobial susceptibility test systems: progress and pitfalls. J Clin Microbiol 56:e201800139-18. https://doi.org/10.1128/JCM.00139-18
Humphries RM, Hindler JA (2016) Emerging resistance, new antimicrobial agents. . . but no tests! The challenge of antimicrobial susceptibility testing in the current US regulatory landscape. Clin Infect Dis 63:83–88. https://doi.org/10.1093/cid/ciw201
Clinical and Laboratory Standards Institute (2015) Performance standards for antimicrobial disc susceptibility testing M02–A12. CLSI, Wayne, PA, USA
Webber DM, Wallace MA, Burnham CA (2022) Stop waiting for tomorrow: disk diffusion performed on early growth is an accurate method for antimicrobial susceptibility testing with reduced turnaround time. J Clin Microbiol 60(5):e03007-e3020. https://doi.org/10.1128/JCM.03007-20
Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376:2235–2244. https://doi.org/10.1056/NEJMoa1703058
CLSI Clinical and Laboratory Standards Institute (2008) Development of in-vitro susceptibility testing criteria and quality control parameters; approved guideline, 3rd edn. CLSI, Wayne PA, USA
Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596
Humphries R (2020) Update on susceptibility testing: genotypic and phenotypic methods. Clin Lab Med 40:433–446. https://doi.org/10.1016/j.cll.2020.08.002
Dubourg G, Lamy B, Ruimy R (2018) Rapid phenotypic methods to improve the diagnosis of bacterial bloodstream infections: meeting the challenge to reduce the time to result. Clin Microbiol Infect 24(9):935–943. https://doi.org/10.1016/j.cmi.2018.03.031
Donghui S, Yu L (2021) Mini-review: Recent advances in imaging-based rapid antibiotic susceptibility testing. Sensors Actuators Rep 3:100053. https://doi.org/10.1016/j.snr.2021.100053. (ISSN 2666-0539)
Foudraine DE, Dekker LJM, Strepis N, Nispeling SJ, Raaphorst MN, Kloezen W, Colle P, Verbon A, Klaassen CHW, Luider TM, Goessens WHF (2022) Using targeted liquid chromatography-tandem mass spectrometry to rapidly detect β-lactam, aminoglycoside, and fluoroquinolone resistance mechanisms in blood cultures growing E. coli or K. pneumoniae. Front Microbiol 13:887420. https://doi.org/10.3389/fmicb.2022.887420
Cenci E, Paggi R, Socio GV, Bozza S, Camilloni B, Pietrella D, Mencacci A (2020) Accelerate Pheno™ blood culture detection system: a literature review. Future Microbiol 15:1595–1605. https://doi.org/10.2217/fmb-2020-0177
Filbrun AB, Richardson JC, Khanal PC, Tzeng YL, Dickson RM (2022) Rapid, label-free antibiotic susceptibility determined directly from positive blood culture. Cytometry A 101(7):564–576. https://doi.org/10.1002/cyto.a.24560
Nix ID, Idelevich EA, Storck LM, Sparbier K, Drews O, Kostrzewa M, Becker K (2020) Detection of methicillin resistance in Staphylococcus aureus from agar cultures and directly from positive blood cultures using MALDI-TOF mass spectrometry-based direct-on-target microdroplet growth assay. Front Microbiol 14(11):232. https://doi.org/10.3389/fmicb.2020.00232
Durand C, Boudet A, Lavigne JP, Pantel A (2020) Evaluation of two methods for the detection of third generation cephalosporins resistant Enterobacterales directly from positive blood cultures. Front Cell Infect Microbiol 11(10):491. https://doi.org/10.3389/fcimb.2020.00491
Stupar P, Opota O, Longo G, Prod’hom G, Dietler G, Greub G et al (2017) Nanomechanical sensor applied to blood culture pellets: a fast approach to determine the antibiotic susceptibility against agents of bloodstream infections. Clin Microbiol Infect 23:400e5
Idelevich EA, Schule I, Grunastel B, Wullenweber J, Peters G, Becker K (2014) Acceleration of antimicrobial susceptibility testing of positive blood cultures by inoculation of Vitek 2 cards with briefly incubated solid medium cultures. J Clin Microbiol 52:4058e62
Le Page S, Raoult D, Rolain JM (2015) Real-time video imaging as a new and rapid tool for antibiotic susceptibility testing by the disc diffusion method: a paradigm for evaluating resistance to imipenem and identifying extended- spectrum beta-lactamases. Int J Antimicrob Agents 45:61e5
Chandrasekaran S, Abbott A, Campeau S et al (2018) Direct-from-blood-culture disk diffusion to determine antimicrobial susceptibility of Gram-negative bacteria: preliminary report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group. J Clin Microbiol 56:e01678-e1717. https://doi.org/10.1128/JCM.01678-17
Jonasson E, Matuschek E, Kahlmeter G (2020) The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother 75:968–978. https://doi.org/10.1093/jac/dkz548
Åkerlund A, Jonasson E, Matuschek E et al (2020) EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories. J Antimicrob Chemother 75:3230–3238. https://doi.org/10.1093/jac/dkaa333
Åkerlund A, Jonasson E, Matuschek E, Serrander L, Sundqvist M, Kahlmeter G, the RAST Study Group (2020) EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories. J Antimicrob Chemother 75(11):3230–3238. https://doi.org/10.1093/jac/dkaa333
Fitzgerald C, Stapleton P, Phelan E, Mulhare P, Carey B, Hickey M, Lynch B, Doyle M (2016) Rapid identification and antimicrobial susceptibility testing of positive blood cultures using MALDI-TOF MS and a modification of the standardised disc diffusion test: a pilot study. J Clin Pathol. jclinpath2015–203436. https://doi.org/10.1136/jclinpath-2015-203436
Humphries RM et al (2018) The continued value of disk diffusion for assessing antimicrobial susceptibility in clinical laboratories: report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group. J Clin Microbiol 56:e00437-e518. https://doi.org/10.1128/JCM.00437-18
Acknowledgements
The authors thank our colleagues from the Department of Microbiology, All India Institute of Medical Sciences, New Delhi, for their insight and guidance. We would also like to thank Dr. Maroof Ahmad Khan for his advice on statistical analysis.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study’s conception and design. Material preparation, data collection, and analysis were performed by Dr. Kavi Priya Appasami and Dr. Jaya Biswas. The first draft of the manuscript was written by Dr. Kavi Priya Appasami and Dr. Jaya Biswas and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
This study involved the use of quality control strains and established clinical isolates. The AIIMS Research Ethics Committee has confirmed that no ethical approval is required.
Consent to participate
Not applicable as this study involved the use of quality control strains and established clinical isolates.
Consent for publication
Not applicable as no confidential patient information has been included in the manuscript.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Biswas, J., Appasami, K.P., Gautam, H. et al. Tick-tock, beat the clock: comparative analysis of disc diffusion testing with 6-, 10-, and 24-h growth for accelerated antimicrobial susceptibility testing and antimicrobial stewardship. Eur J Clin Microbiol Infect Dis 42, 929–943 (2023). https://doi.org/10.1007/s10096-023-04611-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-023-04611-y